Dr. Jordan Dimitrakoff is a Medical Officer at the Division of Urology, Obstetrics, and Gynecology at the Food and Drug Administration. Dr. Dimitrakoff is a nationally-recognized expert in chronic pelvic pain syndrome. He has published more than 50 peer-reviewed articles, including three evidence-based meta-analyses on the pharmacologic management of painful bladder syndrome/interstitial cystitis (PBS/IC) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) which serve as the basis of the evidence-based clinical diagnosis and treatment of urologic chronic pelvic pain syndrome (UCPPS). One of his papers is included in the American Medical Association (AMA) reference topic collections on pain, evidence-based medicine, women’s health and urology. In 2008, Dr. Dimitrakoff founded the Multidisciplinary Approach to Pelvic Pain (MAPP) Discovery Site at Harvard Medical School in Boston, Massachusetts, an NIH-funded initiative. Prior to his tenure at the FDA, he was a regular participant in the NIH-sponsored meetings of the International Chronic Prostatitis Collaborative Research Network (CPCRN) and the Interstitial Cystitis Clinical Trials group (ICCTG). Currently, he is actively involved in medical student teaching and mentoring at USUHS. He was nominated for the Donald O’Hara Faculty Prize for Excellence in Teaching awarded by the Academy for Teaching at Harvard Medical School. Most recently, he was elected Member of the Gold Humanism Honor Society in 2022, based on his nomination by the Uniformed Services University of the Health Sciences Medical Students Class of 2023.